Vaximm AG

City:

Basel

Country:

Switzerland

Published Applications:

Last publication date:

2022-09-01

Patent Grants:

Last grant date:

2022-06-14

Top Inventors for applications by Vaximm AG

These are the the leading inventors for applications assigned to Vaximm AG:

Heinz Lubenau 8 Neustadt an der Weinstrasse, Germany
Heinz Lubenau 1 Neustadl an der Weinstrasse, Germany
Marco Springer 1 Wendlingen, Germany
Holger Siede 1 Ronnenberg, Germany

Renate Janssen 1 Hannover, Germany

Recent patent applications by Vaximm AG

Vaximm AG based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-09-01

US20220273782A1

Human necessities

Novel PD-L1 Targeting DNA Vaccine for Cancer Immunotherapy

#2 | 2020-03-19 ✅ Patent 11,357,842 granted on 2022-06-14

US20200085928A1

Human necessities

PD-L1 targeting DNA vaccine for cancer immunotherapy

#3 | 2020-02-06 ✅ Patent 10,980,868 granted on 2021-04-20

US20200038496A1

Human necessities

VEGFR-2 targeting immunotherapy approach

#4 | 2019-06-20 ✅ Patent 10,821,163 granted on 2020-11-03

US20190183996A1

Human necessities

Process for the production of a DNA vaccine for cancer immunotherapy

#5 | 2019-01-10 ✅ Patent 10,293,037 granted on 2019-05-21

US20190008936A1

Human necessities

DNA vaccine for use in pancreatic cancer patients

#6 | 2018-09-06 ✅ Patent 10,905,752 granted on 2021-02-02

US20180250345A1

Human necessities

VEGFR-2 targeting DNA vaccine for combination therapy

#7 | 2015-06-18 ✅ Patent 9,415,098 granted on 2016-08-16

US20150165011A1

Human necessities

DNA vaccine for use in pancreatic cancer patients

#8 | 2014-11-27 ✅ Patent 9,493,738 granted on 2016-11-15

US20140349274A1

Chemistry; metallurgy

Method for producing high yield attenuated strains

Also check out VAXIMM AG's (Basel, Switzerland) applicant profile with 10 patent applications submitted.

AssigneeID:

83542 ⎘